BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 27364943)

  • 21. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
    Moellman JJ; Bernstein JA
    J Emerg Med; 2012 Aug; 43(2):391-400. PubMed ID: 22285754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review.
    Bork K; Steffensen I; Machnig T
    Allergy Asthma Proc; 2013; 34(4):312-327. PubMed ID: 23710659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
    Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
    Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.
    Bork K; Davis-Lorton M
    Eur Ann Allergy Clin Immunol; 2013 Feb; 45(1):7-16. PubMed ID: 23678554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.
    Farkas H; Martinez-Saguer I; Bork K; Bowen T; Craig T; Frank M; Germenis AE; Grumach AS; Luczay A; Varga L; Zanichelli A;
    Allergy; 2017 Feb; 72(2):300-313. PubMed ID: 27503784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
    Caballero T; Farkas H; Bouillet L; Bowen T; Gompel A; Fagerberg C; Bjökander J; Bork K; Bygum A; Cicardi M; de Carolis C; Frank M; Gooi JH; Longhurst H; Martínez-Saguer I; Nielsen EW; Obtulowitz K; Perricone R; Prior N;
    J Allergy Clin Immunol; 2012 Feb; 129(2):308-20. PubMed ID: 22197274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
    Bork K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary angioedema with normal C1-INH (HAE type III).
    Riedl MA
    J Allergy Clin Immunol Pract; 2013; 1(5):427-32. PubMed ID: 24565612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.
    Khan DA
    Allergy Asthma Proc; 2011; 32(1):1-10. PubMed ID: 21262092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.
    Farkas H
    Paediatr Drugs; 2018 Apr; 20(2):135-151. PubMed ID: 29214395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hereditary angioedema: strange cause of abdominal pain].
    Salas-Lozano NG; Meza-Cardona J; González-Fernández C; Pineda-Figueroa L; de Ariño-Suárez M
    Cir Cir; 2014; 82(5):563-6. PubMed ID: 25259437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Roles for C1 Inhibitor in Transplantation.
    Berger M; Baldwin WM; Jordan SC
    Transplantation; 2016 Jul; 100(7):1415-24. PubMed ID: 26599489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
    Czaller I; Csuka D; Zotter Z; Veszeli N; Takács E; Imreh É; Varga L; Farkas H
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):175-9. PubMed ID: 27364943
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.